ENvue Medical (FEED) Revenue Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | 22.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.64% |
| Dec 31, 2025 | 71.67% |
| Sep 30, 2025 | 95.25% |
| Jun 30, 2025 | 0.61% |
| Mar 31, 2025 | 55.62% |
| Dec 31, 2024 | -16.95% |
| Sep 30, 2024 | -9.00% |
| Jun 30, 2024 | 36.96% |
| Mar 31, 2024 | 107.56% |
| Dec 31, 2023 | 135.60% |
| Sep 30, 2023 | 45.07% |
| Jun 30, 2023 | 3.01% |
| Mar 31, 2023 | 45.89% |
| Dec 31, 2022 | -46.94% |
| Sep 30, 2022 | -1.34% |
| Jun 30, 2022 | 22.63% |
| Mar 31, 2022 | 51.00% |
| Dec 31, 2021 | 143.02% |
| Sep 30, 2021 | 109.85% |
| Jun 30, 2021 | 34.06% |
| Mar 31, 2021 | 10.18% |
| Dec 31, 2020 | 8.74% |
| Sep 30, 2020 | 32.15% |
| Jun 30, 2020 | 72.95% |
| Mar 31, 2020 | 29.91% |
| Dec 31, 2019 | 21.09% |
| Sep 30, 2019 | 18.30% |
| Jun 30, 2019 | 61.88% |
| Mar 31, 2019 | 11.49% |
| Dec 31, 2018 | 11.46% |
| Sep 30, 2018 | 10.52% |
| Jun 30, 2018 | 50.14% |
| Mar 31, 2018 | 38.47% |
| Dec 31, 2017 | 10.42% |
| Sep 30, 2017 | 37.51% |
| Jun 30, 2017 | -6.69% |
| Mar 31, 2017 | -5.69% |